SMYD2 and pancreatic neoplasm: This SMYD2-mediated MNAT1 upregulation activates the phosphoinositide 3-kinase (PI3K)/AKT serine/threonine kinase (AKT) pathway, leading to increased proliferation of pancreatic cancer cells27.